The growth of interventional oncology market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and the increasing government investments …
Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and …
The downstream processing market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.). In the downstream processing market, the major players are Thermo Fisher Scientific Inc. (U.S.), …
The global live cell encapsulation market was valued at USD 250 million in 2018 and is projected to reach USD 303 million by 2024, at a CAGR of 3.2% during the forecast period. The rising number of target patient population, increasing public-private investments to support …
The glycobiology market across the globe is witnessing high growth. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of this market. On the other …